The global single-use bioreactor market is facing potential growth owing to the rise in acquirement of single-use bioreactors and rising need for biologics globally. Furthermore, increasing cases of chronic and inflammatory disorders and the COVID-19 is anticipated to propel the market growth. Anyhow, factors such as official concerns associated to single-use bioreactors and high regular recurring expenditures are anticipated to hinder growth of the market.
Regionally, the global single-use bioreactor market is divided into Asia Pacific, North America, Latin America, Europe, and Middle East & Africa.
By Region, North America is anticipated to gain huge share in the market over the predicted duration due to the rising cases of chronic disorders and rise in acquirement of single-use technologies by key players in the region. For example, as per the CDC, chronic disorders, such as cardiovascular disorders, tumor, and mellitus, are the leading developments of death and disorders in the U.S. Six in ten Americans suffer with at least one chronic disorder, such as CVD and stroke, tumor, or mellitus. This further is anticipated to fuel the growth of the market in the region.
Asia Pacific is also anticipated to witness strong growth in the global single-use bioreactor market due to the rising cases of chronic disorder and quick growth of the in pharma industry the region. For example, as per the IBEF, India’s domestic pharma market valued at US$ 42 billion in 2021 and is anticipated to reach over US$ 65 billion by 2024 and to cross US$ 120-130 billion by 2030. Protection, inexpensive, and decreased downtime are the main factors for the increase of single-use bioreactors in the pharma industry, fueling the growth of the market.
Click Here to Get a Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/5358
Increase in acquirement of single-use bioreactors by the pharma sector is anticipated to propel growth of the global single-use bioreactor market over the predicted duration. For example, single-use bioreactors are developing as a key technology in the sector of pharma. In March 2021, Thermo Fisher rolled out 3,000 and 5,000 L S.U.B. The first-of-its-size 5,000 L S.U.B. is Thermo’s largest commercially accessible S.U.B., allowing biopharma organizations to collaborate single-use techniquees into large-scale bioprocesses, comprising perfusion cell culture and cGMP production at very huge cell density.
Rising need for biologics globally is anticipated to propel growth of the global single-use bioreactor market during the predicted timeline. For example, the rise in the growth of biologics globally has led to a rise in need for SUBs. In November 2022, Juvena Therapeutics, Inc. invested US$ 41 million in an oversubscribed Series A, bringing its total investment to US$ 50 million. The new investment will power the increment of Juvena’s drug discovery service and develop the organizations biologics pipeline targeting chronic and age-related disorders. This further is propelling the single-use bioreactor market growth.
Increasing burden of chronic and inflammatory disorder globally is anticipated to provide significant growth opportunities for companies in the single-use bioreactor market. For example, bioreactors have been utilized for decades to offer a range of therapies, showing results for the therapy of many acute and chronic disorders. Chronic disorders are the leading reasons of mortality and morbidity globally. As per the WHO, heart disorders hold for most NCD mortalities, or 17.9 million people yearly, after tumor (9.3 million), chronic respiratory disorders (4.1 million), and mellitus (2.0 million).
COVID-19 Outbreak globally is anticipated to offer notable growth opportunities for players in the global single-use bioreactor market. For example, bioreactors are being vastly utilized in cell culture-based viral immunizer manufacture, especially over the COVID-19 outbreak. In September 2020, ABEC offered six 4,000L CSR bioreactors to Serum Institute of India to increase the production of NVX CoV2373, Novavax’ COVID-19 vaccine candidate. Furthermore, Serum Institute had utilized ABEC’s single-use technology to increase supply of NVX CoV2373 overall in India and other LMICs.
Single-use bioreactors are especially appropriate for biopharma manufacture, while prevailing market trends need rapid, easy and flexible disposition. Single-use bioreactors improve procedure protection and decrease the threat of cross contamination in vastly potent biopharma components with extra validation and qualification procedure. Resulting, there is a rise in need for single-use bioreactors, and this trend is anticipated to continue over the predicted duration.
Furthermore, there is a rise in need for single-use bioreactors owing to the rise in chronic disorders combined with the developing requirement for innovating new medicines. Chronic disorders, such as heart disorders, mellitus, and cancer, are the dominating disorders of fatality and disorders globally. Hence, with the rise in cases of chronic disorder, the necessity for developing new medicines is also enhancing with a quick pace. This trend is anticipated to continue in predicted timeframe, propelling the growth of the global single-use bioreactor market.
Official concerns associated to single-use bioreactors is anticipated to hinder growth of the global single-use bioreactor market. For example, SUBs have become a recognized addition to current biotechnology production service. Many single-use bioreactors are made of plastic byproducts. Large-scale disposal of such plastic reactors is a surrounding issue, and a major test, particularly in regions where plastic disposal is strictly maintained.
Huge regular recurrent cost are anticipated to impede growth of the single-use bioreactor market. For example, recurring cost for single-use bioreactors has been known to be huge. Furthermore, the cost included in the waste management of large standards of disposables is also heavy. SUBs incur more disposal price in comparison to reusable units, which anyways has huge upfront price in terms of installation and regulation.
Ask For Discount Before Purchasing This Business Report : https://www.coherentmarketinsights.com/insight/request-discount/5358
The global single-use bioreactor market report is divided into Molecule Type, Product, Cell Type, End User, and Geography.
Based on Product, the single-use bioreactor market is divided into Single-Use Bioreactor Systems, Filtration Assemblies, Media Bags, and Other Products. Out of which, Single-Use Bioreactor Systems Segment is anticipated to lead the single-use bioreactor market during the predicted timeline and this is owing to the rise in acquirement of single-use bioreactors by the pharma and biopharma organizations.
Media Bags Segment is also anticipated to witness considerable growth in the near future and this is due to the benefits of utilizing media bags and developments in the bag material.
Based on Cell Type, the market is divided into Yeast, Mammalian Cell, Bacteria, and Other Cell Types. Out of which, Mammalian Cell Segment is anticipated to lead the market during the predicted duration and this is owing to the increase in mammalian cell culture. Single-use bioreactors are uniquely utilized for the mammalian cell bioprocessing.
Bacteria Segment is also anticipated to advocate significant growth in the near future and this is due to the rising use of single-use bioreactor in bacterial culture.
Based on Molecule Type, the market is divided into Stem Cells, Vaccines, Monoclonal Antibodies, Recombinant Proteins, and Other Molecule Types. Out of which, Vaccines Segment is anticipated to lead the market during the predicted duration and this is owing to the COVID-19 pandemic. Bioreactors are vastly utilized in cell culture-based viral vaccine manufacture, particularly through the COVID-19 pandemic.
Stem Cells Segment is also anticipated to advocate notable development in the near future and this is due to the rise in growth of regenerative drugs. This further has rising need for stem cells and their derivatives.
Based on End User, the market is divided into pharma and Biopharmaceutical Industries and CRO, and Other End Users. Out of which, Pharmaceutical and Biopharmaceutical Industries Segment is anticipated to lead the global single-use bioreactor market during the predicted duration and this is owing to the increase in acquirement of single-use bioreactors by these industries.
Global Single-Use Bioreactor Market: Key Developments
In April 2020, Celltainer Biotech BV strategic to collaborate with PAN-Biotech, to provide integrated methods for cell culture procedure.
In September 2019, Abec Inc. declared the approval of the single-use bioreactor with a capacity of 6,000 L to offer performance in comparison to stainless steel methods.
Global Single-Use Bioreactor Market: Key Companies Insights
The global single-use bioreactor market is vastly competitive. This is owing to the rise in need for single-use bioreactors globally, as a result, companies in the market are aiming on clearance of new goods in the market.
Few key players in the global single-use bioreactor market are:
Sartorius AG, Celltainer Biotech BV, ABEC Inc., OmniBRx Biotechnologies, Thermo Fisher Scientific, Merck KgaA, Solaris Biotechnology Srl, Eppendorf AG, Distek Inc., and Danaher Corporation (Pall Corporation), among others.
Buy This Complete Business Report @ https://www.coherentmarketinsights.com/insight/buy-now/5358
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Single-Use Bioreactor Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: Single-Use Bioreactor Industry Impact
Chapter 2 Global Single-Use Bioreactor Competition by Types, Applications, and Top Regions and Countries
2.1 Global Single-Use Bioreactor (Volume and Value) by Type
2.3 Global Single-Use Bioreactor (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Single-Use Bioreactor Sales, Consumption, Export, Import by Regions (2017-2022)
Chapter 5 North America Single-Use Bioreactor Market Analysis
Chapter 6 East Asia Single-Use Bioreactor Market Analysis
Chapter 7 Europe Single-Use Bioreactor Market Analysis
Chapter 8 South Asia Single-Use Bioreactor Market Analysis
Chapter 9 Southeast Asia Single-Use Bioreactor Market Analysis
Chapter 10 Middle East Single-Use Bioreactor Market Analysis
Chapter 11 Africa Single-Use Bioreactor Market Analysis
Chapter 12 Oceania Single-Use Bioreactor Market Analysis
Chapter 13 South America Single-Use Bioreactor Market Analysis
Chapter 14 Company Profiles and Key Figures in Single-Use Bioreactor Business
Chapter 15 Global Single-Use Bioreactor Market Forecast (2022-2028)
Chapter 16 Conclusions
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
533 Airport Boulevard, Suite 400, Burlingame,
CA 94010, United States.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027